Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes.

about

Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes.

Item

http://www.wikidata.org/entity/Q35605398

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Requirement of Innate Immunity ...... ng Tumor-Draining Lymph Nodes.

@ast

Requirement of Innate Immunity ...... ng Tumor-Draining Lymph Nodes.

@en

type

Item

label

Requirement of Innate Immunity ...... ng Tumor-Draining Lymph Nodes.

@ast

Requirement of Innate Immunity ...... ng Tumor-Draining Lymph Nodes.

@en

prefLabel

Requirement of Innate Immunity ...... ng Tumor-Draining Lymph Nodes.

@ast

Requirement of Innate Immunity ...... ng Tumor-Draining Lymph Nodes.

@en

P1476

Requirement of Innate Immunity ...... ng Tumor-Draining Lymph Nodes.

@en

P2093

Hallie Graor

http://www.w3.org/2001/XMLSchema#string

John Ammori

http://www.w3.org/2001/XMLSchema#string

Julian Kim

http://www.w3.org/2001/XMLSchema#string

Khaled Hamzeh

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy.

Interleukin-21 augments the efficacy of T-cell therapy by eliciting concurrent cellular and humoral responses.

Peptide-based cancer vaccines.

Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression

Adoptive cell therapy for the treatment of patients with metastatic melanoma.

Expansion of melanoma-specific T cells from lymph nodes of patients in stage III: implications for adoptive immunotherapy in treating cancer.

Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.

P304

170852

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/170852

http://www.w3.org/2001/XMLSchema#string

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277360762

http://www.w3.org/2001/XMLSchema#string

P698

26090481

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

P932

4431318

http://www.w3.org/2001/XMLSchema#string